Response to oral sucrosomial iron supplementation in patients undergoing bariatric surgery. The BARI-FER study
Endocrinol Diabetes Nutr (Engl Ed). 2018 Jan;65(1):17-20.
doi: 10.1016/j.endinu.2017.10.007.
Epub 2017 Dec 7.
[Article in
English,
Spanish]
Affiliations
- 1 Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain; CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Spain; Endocrinology and Nutrition Department, Vall d'Hebron University Hospital, Barcelona, Spain. Electronic address: aciudin@vhebron.net.
- 2 Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain; CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Spain; Endocrinology and Nutrition Department, Vall d'Hebron University Hospital, Barcelona, Spain.
- 3 Bariatric Surgery Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Abstract
Background:
Chronic intravenous iron administration is often required after bariatric surgery. Oral sucrosomial iron has a particular form of absorption and may represent an alternative treatment.
Objective:
To assess the effect of switching to oral sucrosomial iron in patients receiving intravenous iron supplementation after bariatric surgery.
Patients and methods:
A case-control study was conducted on 40 women of childbearing age, of whom 20 were switched to oral sucrosomial iron, while 20 patients continued on intravenous iron sucrose every three months.
Results:
No significant differences were seen in Hb, ferritin, and TSI levels before and after three months of treatment with sucrosomial iron.
Conclusion:
Oral sucrosomial iron could be an alternative in patients who require parenteral treatment with iron after bariatric surgery.
Keywords:
Anaemia ferropénica; Bariatric surgery; Cirugía bariátrica; Deficiency anaemia; Hierro sucrosomado; Sucrosomial iron.
Copyright © 2017 SEEN y SED. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Administration, Oral
-
Adult
-
Anemia, Iron-Deficiency / etiology
-
Anemia, Iron-Deficiency / prevention & control
-
Case-Control Studies
-
Comorbidity
-
Drug Substitution
-
Female
-
Ferric Oxide, Saccharated / administration & dosage
-
Ferric Oxide, Saccharated / pharmacokinetics
-
Ferric Oxide, Saccharated / therapeutic use*
-
Ferritins / blood
-
Gastric Bypass / adverse effects*
-
Hemoglobins / analysis
-
Humans
-
Infusions, Intravenous
-
Intestinal Absorption
-
Iron Deficiencies
-
Iron, Dietary / pharmacokinetics
-
Malabsorption Syndromes / drug therapy*
-
Malabsorption Syndromes / etiology
-
Middle Aged
-
Young Adult
Substances
-
Hemoglobins
-
Iron, Dietary
-
Ferritins
-
Ferric Oxide, Saccharated